Apnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch

Fuente: FierceBiotech
Apnimed has raised $192 million for its upsized IPO, with the proceeds earmarked to fund the launch of its sleep apnea pill.
Volver